Cardiovascular CRO
THE HEART OF THE MATTER – INNOVATION WHERE IT MATTERS MOST
Despite tremendous progress in improving cardiovascular outcomes, cardiovascular disease remains the leading cause of death in the U.S. and around the world. Cardiovascular disease and quality of care remain urgent public health issues demanding innovative and accelerated solutions.
A global team, focused on your opportunity
As a global cardiovascular CRO, we work with innovative companies at the forefront of cardiovascular disease product development. This includes small to midsize biotech companies who turn to our specialized Cardiovascular team for deep therapeutic expertise, our therapeutic alignment – meaning our 100% focus on cardiology, from our senior leadership and project managers to our CRAs – and our flexible, creative approach to meeting complex challenges.
We’ve worked across the entire spectrum of cardiovascular indications including hypertension, atrial fibrillation, heart failure, ischemic heart disease, thrombosis, dyslipidemia, diabetes, obesity and many more. We are also experienced in the clinical development of new therapies such as stem cells, HFpEF, HFrEF, SGLT-2 inhibitors and large, global cardiovascular outcome trials (CVOT).
Focus on the patient experience through cardiovascular clinical research
The contributions patients can make to the cardiovascular clinical research enterprise are invaluable. We learn from them to map their journey to inform study goals and reduce the burden of trial participation by using home health, telemedicine and digital technology platforms to facilitate decentralized solutions.
Best-in-class cardiovascular site network
With our dedicated focus on cardiovascular disease, we’ve built a global, trusted, network of more than 2,200 sites specializing in cardiovascular studies. These are the high-performing sites you want to work with in order to meet recruitment targets, enroll the right patients, optimize study start-up and ensure operational excellence.m.
Ready to see what our Cardiology team can do for you?
Taking studies to where the patients are
Digital health technologies have the potential to increase efficiency and data capture, while creating exciting new ways to accelerate patient access, improve retention and increase diversity. We combine deep insights, agile technologies, innovative trial design experience and operational excellence to bring clinical trials closer to the patient.
Capturing value with real world evidence
Real world evidence (RWE) acts as the critical bridge from clinical effectiveness to a commercially viable brand, driving speed and value across the product lifecycle. Syneos Health is ready to be your partner of choice to support next-generation RWE delivery across the product development lifecycle.
